IOL
Conditions
Brief summary
To collect data on bilateral pseudophakic patients implanted with the RxSight Light Adjustable Lens (LAL) in at least one eye
Interventions
DEVICELight Adjustable Lens
The Light Adjustable Lens (LAL) is a posterior chamber, UV absorbing, three-piece, foldable, photoreactive silicone intraocular lens with a squared posterior optic edge intended to be implanted in the capsular bag following phacoemulsification. Selective exposure of the implanted RxSight LAL using the Light Delivery Device (LDD) to deliver a spatially profiled UV light produces modifications in the lens curvature resulting in a spherical or spherocylindrical power change post-operatively. A subsequent lock-in exposure is delivered to the implanted LAL to stabilize the lens power.
Sponsors
Bucci Laser Vision Institute
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults with bilateral pseudophakia who have been implanted with the LAL in at least one eye and who have completed LDD light treatments
Exclusion criteria
* Visually significant eye disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient Satisfaction - subjective questionnaire | 3-18 months after cataract surgery | Subjective questionnaire explores the frequency/need for glasses for various visual functions at distance/intermediate/near, experience with dysphotopsias, and overall satisfaction of visual function without glasses. |
Countries
United States
Outcome results
None listed